These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10094217)
1. Reduction in health care resource utilization associated with extended-release theophylline. Schulz RM; Yates WN Ann Allergy Asthma Immunol; 1999 Mar; 82(3):267-72. PubMed ID: 10094217 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients. Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862 [TBL] [Abstract][Full Text] [Related]
3. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Friedman HS; Yawn BP Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696 [TBL] [Abstract][Full Text] [Related]
4. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Delea TE; Hagiwara M; Stanford RH; Stempel DA Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796 [TBL] [Abstract][Full Text] [Related]
5. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006 [TBL] [Abstract][Full Text] [Related]
6. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma. Stempel DA; Riedel AA; Carranza Rosenzweig JR Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030 [TBL] [Abstract][Full Text] [Related]
7. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
8. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population. Nestor A; Calhoun AC; Dickson M; Kalik CA Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496 [TBL] [Abstract][Full Text] [Related]
9. Profile of children requiring emergency treatment for asthma. Friday GA; Khine H; Lin MS; Caliguiri LA Ann Allergy Asthma Immunol; 1997 Feb; 78(2):221-4. PubMed ID: 9048532 [TBL] [Abstract][Full Text] [Related]
10. Ambulatory care visits for asthma: United States, 1993-94. Burt CW; Knapp DE Adv Data; 1996 Sep; (277):1. PubMed ID: 10166755 [TBL] [Abstract][Full Text] [Related]
11. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus. Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392 [TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities. O'Connor RD; Parasuraman B; Roberts C; Leibman C Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758 [TBL] [Abstract][Full Text] [Related]
13. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
14. Evidence for benefits of early intervention with non-steroidal drugs in asthma. König P Pediatr Pulmonol Suppl; 1997 Sep; 15():34-9. PubMed ID: 9316100 [TBL] [Abstract][Full Text] [Related]
15. Current options in the treatment of acute bronchospasm. Berger WE Postgrad Med; 2005 Dec; 118(6 Suppl Acute):18-26. PubMed ID: 19667712 [TBL] [Abstract][Full Text] [Related]
16. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma. Davies GM; Dasbach EJ; Santanello NC; Knorr BA; Bratton DL Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701 [TBL] [Abstract][Full Text] [Related]
17. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
19. Costs and resource use of mild persistent asthma patients initiated on controller therapy. Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593 [TBL] [Abstract][Full Text] [Related]
20. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma. Wong MD; Manley RT; Stettin G; Chen W; Salmun LM Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]